Paricalcitol recalls
The FDA has published 11 recalls involving Paricalcitol since 2012. The latest was reported on 26 Oct 2016. Most were for potency & assay. Teva Pharmaceuticals USA has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls 11 since 2012
Last 12 months 0 reported
Class I 0 0% of total
Ongoing 0 latest 26 Oct 2016
Recalls per month, last 24 months click a bar for that month Severity split
0 0%3 27%8 73%
Why paricalcitol is recalled
All paricalcitol recalls, newest first 11 total Reported Class Recall Company Reason Where 26 Oct 2016 Drug CLASS III Paricalcitol Capsules, 1 mcg recalled by Teva Pharmaceuticals U Teva Pharmaceuticals USA Potency & Assay Nationwide 26 Oct 2016 Drug CLASS III Paricalcitol Capsules, 4 mcg recalled by Teva Pharmaceuticals U Teva Pharmaceuticals USA Potency & Assay Nationwide 26 Oct 2016 Drug CLASS III Paricalcitol Capsules, 2 mcg recalled by Teva Pharmaceuticals U Teva Pharmaceuticals USA Potency & Assay Nationwide 19 Oct 2016 Drug CLASS III Paricalcitol Capsules, 1 mcg recalled by Amerisource Health Services Amerisource Health Services Potency & Assay Nationwide 27 Apr 2016 Drug CLASS III Zemplar (paricalcitol) capsules, 1 mcg recalled by AbbVie Zemplar AbbVie Other Nationwide 23 Mar 2016 Drug CLASS II Paricalcitol Capsules, 1 mcg recalled by Teva Pharmaceuticals U Teva Pharmaceuticals USA Potency & Assay Nationwide 24 Feb 2016 Drug CLASS III Paricalcitol Capsules, 4 mcg recalled by Dr. Reddy's Laboratories Paricalcitol Dr. Reddy's Laboratories Packaging Defects Nationwide 24 Feb 2016 Drug CLASS III Paricalcitol Capsules, 2 mcg recalled by Dr. Reddy's Laboratories Paricalcitol Dr. Reddy's Laboratories Packaging Defects Nationwide 24 Feb 2016 Drug CLASS III Paricalcitol Capsules, 1 mcg recalled by Dr. Reddy's Laboratories Paricalcitol Dr. Reddy's Laboratories Packaging Defects Nationwide 29 Jan 2014 Drug CLASS II Paricalcitol, Capsule, 1 mcg recalled by Aidapak Services Aidapak Services Labeling Errors 4 states 27 Jun 2012 Drug CLASS II Zemplar (paricalcitol) Injection, 5 mcg/mL recalled Zemplar Abbott Laboratories Manufacturing (CGMP) Deviations Nationwide
Should you stop taking Paricalcitol?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.